Decide at what price you'd be comfortable buying and we'll help you stay ready.
AMD pairs rapid, uneven growth and variable reported margins with research spending that substantially exceeds physical capital investment. Free cash flow has remained positive throughout the supplied annual history, although working-capital absorption makes cash conversion uneven.
The latest quarter extended operating-margin expansion but brought a sharp drop in cash conversion as inventory and capacity investment supported the Data Center ramp. Positive trailing free cash flow indicates a more cash-demanding growth phase rather than a demonstrated break in the financial model.
Whether inventory and receivable growth moderate enough for operating cash flow to catch up with earnings while capacity investment continues.
| Metric | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 4.3B | 5.3B | 6.5B | 6.7B | 9.8B | 16.4B | 23.6B | 22.7B | 25.8B | 34.6B | |
| (3.3B) | (3.5B) | (4B) | (3.9B) | (5.4B) | (8.5B) | (13B) | (12.2B) | (13.1B) | (17.5B) | |
| 998m | 1.8B | 2.4B | 2.9B | 4.3B | 7.9B | 10.6B | 10.5B | 12.7B | 17.2B | |
| (1.5B) | (1.7B) | (2B) | (2.3B) | (3B) | (4.3B) | (9.4B) | (10.1B) | (10.7B) | (13.5B) | |
| (460m) | (516m) | (562m) | (750m) | (995m) | (1.4B) | (2.3B) | (2.4B) | (2.8B) | (4.1B) | |
| (1B) | (1.2B) | (1.4B) | (1.5B) | (2B) | (2.8B) | (5B) | (5.9B) | (6.5B) | (8.1B) | |
| 0 | — | — | — | — | — | (2.1B) | (1.9B) | (1.4B) | (1.2B) | |
| (470m) | 75m | 451m | 571m | 1.4B | 3.6B | 1.2B | 367m | 2B | 3.7B | |
| (153m) | (123m) | (106m) | (80m) | (39m) | 30m | (85m) | 99m | 92m | 450m | |
| 156m | 126m | 121m | 94m | 47m | 34m | 88m | 106m | 92m | 131m | |
| 30m | 40m | (12m) | (116m) | (54m) | 5m | 102m | 34m | (138m) | 0 | |
| 145m | 0 | (3m) | (3m) | (1m) | (2m) | 5m | (8m) | (3m) | (4m) | |
| (448m) | (8m) | 330m | 372m | 1.3B | 3.7B | 1.2B | 492m | 2B | 4.1B | |
| (39m) | (1.1B) | 22m | (44m) | 1.2B | (513m) | 122m | 346m | (381m) | 103m | |
| (487m) | (1.2B) | 352m | 328m | 2.5B | 3.2B | 1.3B | 838m | 1.6B | 4.2B | |
| (10m) | (7m) | (2m) | 0 | 5m | 6m | 14m | 16m | 33m | 26m | |
| (497m) | (33m) | 337m | 341m | 2.5B | 3.2B | 1.3B | 854m | 1.6B | 4.3B | |
| (0.60) | (0.03) | 0.33 | 0.29 | 2.06 | 2.57 | 0.84 | 0.53 | 1.00 | 2.64 |
Alpha Spread
Preferences
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
New to Alpha Spread? Create free account
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Already have an account? Sign in
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more